date,title,source
Oct-18-18,Orgenesis CEO to Participate in Panel Presentation at The Cellular Living Drug Revolution Summit in New York City,GlobeNewswire
Oct-18-18,Orgenesis Subsidiary Masthercell Global Announces Manufacturing Services Agreement with Iovance Biotherapeutics in Europe,GlobeNewswire
Oct-18-18,Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe,GlobeNewswire
Oct-19-18,Orgenesis Announces Collaboration with Immugenyx to Develop and Commercialize Advanced Hematopoietic Chimeras,GlobeNewswire
Oct-22-18,Orgenesis Announces Collaboration with Hemogenyx to Develop Blood Stem Cell Replacement Product,GlobeNewswire
Oct-23-18,Orgenesis to Present at Dawson James Securities 4th Annual Small Cap Growth Conference,GlobeNewswire
Nov-15-18,How Does Orgenesis Inc (NASDAQ:ORGS) Affect Your Portfolio Volatility?,Simply Wall St.
Nov-19-18,"Detailed Research: Economic Perspectives on Miller Industries, P & F Industries, Schmitt Industries, Orgenesis, AMERI, and TrovaGene  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Nov-21-18,"Orgenesis Announces Collaboration with the New York Blood Center for Tissue Collection, Processing and Biobanking U.S. Cell Therapy Development Program",GlobeNewswire
Nov-30-18,Orgenesis Subsidiary Masthercell Global Expands Production and Doubles its Capacity,GlobeNewswire
Dec-12-18,Orgenesis CEO Vered Caplan to Present at William Blairs Biotech Focus Day Series: Cell and Gene Therapy Manufacturing,GlobeNewswire
Dec-12-18,Orgenesis Announces Collaboration with Ben-Gurion University to Research and Develop Dissolvable Carriers for Cell Culturing,GlobeNewswire
Dec-13-18,Orgenesis CEO Vered Caplan to Appear on Fox Business Networks Mornings with Maria,GlobeNewswire
Dec-18-18,Orgenesis Announces Collaboration with MangoGen Pharma for Advanced Gene Delivery Platform,GlobeNewswire
Dec-31-18,Penny Stocks to Buy Using Technical Analysis for January 2019,Investopedia
Dec-31-18,"Analysis: Positioning to Benefit within PPL, Inseego, Scientific Games, Orgenesis, CUI Global, and TRACON Pharmaceuticals  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Jan-03-19,Orgenesis CEO Selected to Participate in Cell and Gene Therapy Workshop at Biotech Showcase 2019 in California,GlobeNewswire
Jan-22-19,Penny Stocks to Buy Using Technical Analysis for January 2019,Investopedia
Jan-22-19,Orgenesis Subsidiary Atvio Biotech to Present at Phacilitate Leaders World 2019 Conference,GlobeNewswire
Jan-25-19,Orgenesis Announces U.S. Expansion of Masthercell Global Subsidiary,GlobeNewswire
Feb-11-19,Orgenesis CEO to Participate in Panel at the 2019 BIO CEO & Investor Conference,GlobeNewswire
Feb-14-19,Orgenesis Reports 85% Increase in Revenue and 139% Increase in Gross Profit for Fiscal 2018,GlobeNewswire
Mar-07-19,Does Orgenesis Inc.s (NASDAQ:ORGS) CEO Pay Compare Well With Peers?,Simply Wall St.
Mar-25-19,Orgenesis Subsidiary Masthercell Global Announces Plans to Establish New Facility for Cell and Gene Therapy Commercial Manufacturing,GlobeNewswire
Mar-27-19,"Orgenesis Inc. Provides 2018 Corporate Highlights, Clinical Development and Growth Drivers for 2019 in New SNNLive Video Interview on StockNewsNow.com",ACCESSWIRE
Mar-28-19,Orgenesis Signs Master Service and Joint Venture Agreement with TheraCell Advanced Biotechnology for the Development of Cell and Gene Therapies,GlobeNewswire
Apr-03-19,Orgenesis Announces Publication of an Independent Study The Role of The Vasculature Niche on Insulin Producing Cells Generated by Transdifferentiation of Adult Human Liver Cells in the Stem Cell Research and Therapy Journal,GlobeNewswire
Apr-04-19,Orgenesis Announces Collaboration with Digilab to Develop Industrial 3D Printing Capability for Cellular Structures and Tissues for Clinical Use,GlobeNewswire
Apr-08-19,Will Orgenesis Inc. (ORGS) Report Negative Q1 Earnings? What You Should Know,Zacks
Apr-11-19,Orgenesis Announces Collaboration and License Agreement for Exosome-Related Technologies with ExcellaBio,GlobeNewswire
Apr-22-19,"Orgenesis Announces Collaboration Agreement with Columbia University to Develop Cellular Vaccination Product Platform for Pancreatic, Hepatic and Cholangiocarcinoma Cancers",GlobeNewswire
